(Press-News.org) About The Study: In 2023, all 3 payer markets (commercial insurance, Medicare Part D, and Medicaid managed care) for pharmacy benefit manager (PBM) services were highly concentrated, but concentration varied and was highest in Medicare Part D. While CVS Caremark held the dominant share in all 3 payer markets, each of the PBMs appeared focused on a different payer: Express Script’s largest share was in the commercial market, while Optum Rx’s and CVS Caremark’s were in Medicare Part D and Medicaid managed care, respectively. These findings underscore the importance of considering payer-specific concentration when evaluating PBMs’ anticompetitive practices, as the 3 top PBMs may be pursuing different market strategies.
Corresponding Author: To contact the corresponding author, Dima M. Qato, PharmD, MPH, PhD, email qato@usc.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2024.17332)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.17332?guestAccessKey=78406ce0-93f9-4de3-a404-3d1abdf4c54f&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=091024
END
Pharmacy benefit manager market concentration for prescriptions filled at US retail pharmacies
JAMA
2024-09-10
ELSE PRESS RELEASES FROM THIS DATE:
New research shows new class of once-weekly insulin as effective as daily injections for patients with type 2 diabetes
2024-09-10
New research published in NEJM and presented at this year’s Annual Meeting of the European Association for the Study of Diabetes (EASD) in Madrid (9-13 Sept) shows that a new class of insulin that is injected once a week is as effective as daily insulin injections for effective and safe blood sugar management in patients with type 2 diabetes. The study is by Dr Carol Wysham, MultiCare Rockwood Center for Diabetes and Endocrinology, Spokane, WA, USA, and colleagues.
When patients with type 2 diabetes find their oral medications alone can no longer control their blood sugar, insulin therapy is added and injection frequency (having daily injections) is among the main factors that can contribute ...
New class of weekly insulin as effective as daily injections for managing blood sugar in patients with type 1 diabetes; but higher rates of hypoglycaemia means vigilance needed (QWINT-5)
2024-09-10
New research published in The Lancet and presented at this year’s Annual Meeting of the European Association for the Study of Diabetes (EASD) in Madrid (9-13 Sept) shows that a new class of insulin that only needs to be injected once weekly is as effective as daily insulin injections for effective blood sugar management in patients with type 1 diabetes. However, higher rates of hypoglycaemia using the new class means vigilance is needed for dose initiation and optimisation. The study is by Dr Richard M Bergenstal, ...
Like father, like daughter
2024-09-10
RIVERSIDE, Calif. -- When they become fathers, men who have an unhealthy, high-cholesterol diet can cause increased risk of cardiovascular disease, or CVD, in their daughters, a University of California, Riverside-led mouse study has found.
The research, published in the journal JCI Insight, is the first to demonstrate this result seen only in female offspring.
CVD, the leading cause of death globally, is a group of disorders that affects the heart and blood vessels. Hypertension (high blood pressure) is a leading risk factor ...
2-bromopalmitate reduces senescence in human cells: Role of palmitoylation
2024-09-10
“For the first time, the present study revealed a critical role for protein palmitoylation in the development of a DNA damage-induced senescence phenotype.”
BUFFALO, NY- September 10, 2024 – A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science), Volume 16, Issue 16 on August 23, 2024, entitled, “2-Bromopalmitate treatment attenuates senescence phenotype in human adult cells - possible role of palmitoylation.”
As ...
Don’t judge a fossil by its teeth: despite its toothy beak, this ancient bird ate fruit, not fish
2024-09-10
For paleontologists who study animals that lived long ago, fossilized remains tell only part of the story of an animal’s life. While a well-preserved skeleton can provide hints at what an ancient animal ate or how it moved, irrefutable proof of these behaviors is hard to come by. But sometimes, scientists luck out with extraordinary fossils that preserve something beyond the animal’s body. Case in point: in a new study published in the journal Current Biology, researchers found fossilized seeds in the stomachs of one of the earliest birds. This discovery shows that these birds were eating ...
A new screening tool to improve telehealth access and equity
2024-09-10
In a new study published in JAMA Network Open, researchers at Thomas Jefferson University have developed a novel screening tool to measure digital health readiness, which will be critical in addressing barriers to telehealth adoption among diverse patient populations.
The COVID-19 pandemic facilitated many rapid changes in healthcare, including a shift to using telehealth services across the U.S. instead of traditional in-person doctor’s visits. This ensured that patients continued to receive vital care, while only needing access to a mobile device or computer with a webcam. But just because a ...
New law regulating out-of-pocket drug spending saves cancer patients more than $7,000 a year, study finds
2024-09-10
For more information, contact:
Nicole Fawcett, nfawcett@umich.edu
EMBARGOED for release at 11 a.m. Sept. 10, 2024
New law regulating out-of-pocket drug spending saves cancer patients more than $7,000 a year, study finds
The Inflation Reduction Act’s limit on Medicare Part D spending leads to significant savings for patients prescribed oral chemotherapy
ANN ARBOR, Michigan — As prescription oral chemotherapies have become a common form of cancer treatment, some patients were paying more than $10,000 a year for medications. A new study ...
Estimated health and economic outcomes of racial and ethnic tuberculosis disparities in US-born persons
2024-09-10
About The Study: In this modeling study of racial and ethnic disparities of tuberculosis (TB), these disparities were associated with substantial future health and economic outcomes of TB among U.S.-born persons without interventions beyond current efforts. Actions to eliminate disparities may reduce the excess TB burden among these persons and may contribute to accelerating TB elimination within the U.S.
Corresponding Author: To contact the corresponding author, Nicole A. Swartwood, MSPH, email nswartwood@hsph.harvard.edu.
To ...
Genetic analysis sheds light on the role of IFT140 in polycystic kidney disease
2024-09-10
Tokyo Medical and Dental University (TMDU) researchers uncover the genetic link in patients with polycystic kidney disease lacking family history
Tokyo, Japan – Polycystic kidney disease (PKD) is an intractable disorder that causes fluid-filled cysts to grow in the kidneys. It is typically seen in adults. As one of the most prevalent hereditary kidney diseases, the autosomal dominant form of PKD is usually caused by mutations in the PKD1 and PKD2 genes. However, one out of ten patients with this condition typically exhibit no family history of the disease and lack ...
Scientists use AI to detect chronic high blood pressure in people’s voice recordings
2024-09-10
NEW YORK/TORONTO – September 10, 2024 – Researchers at Klick Labs unveiled a cutting-edge, non-invasive technique that can predict chronic high blood pressure (hypertension) with a high degree of accuracy using just a person's voice. Just published in the peer-reviewed journal IEEE Access, the findings hold tremendous potential for advancing early detection of chronic high blood pressure and showcase yet another novel way to harness vocal biomarkers for better health outcomes.
The ...
LAST 30 PRESS RELEASES:
ESMT Berlin research shows private ownership boosts hospital performance
The risk of death or complications from broken heart syndrome was high from 2016 to 2020
Does adapting to a warmer climate have drawbacks?
Team develops digital lab for data- and robot-driven materials science
Got data? Breastfeeding device measures babies’ milk intake in real time
Novel technology enables better understanding of complex biological samples
Autistic people communicate just as effectively as others, study finds
Alaska: Ancient cave sediments provide new climate clues
Adult-onset type 1 diabetes increases risk of cardiovascular disease and death
Onion-like nanoparticles found in aircraft exhaust
Chimpanzees use medicinal leaves to perform first aid
New marine-biodegradable polymer decomposes by 92% in one year, rivals nylon in strength
Manitoba Museum and ROM palaeontologists discover 506-million-year-old predator
Not all orangutan mothers raise their infants the same way
CT scanning helps reveal path from rotten fish to fossil
Physical activity + organized sports participation may ward off childhood mental ill health
Long working hours may alter brain structure, preliminary findings suggest
Lower taxes on Heated Tobacco Products are subsidizing tobacco industry – new research
Recognition from colleagues helps employees cope with bad work experiences
First-in-human study of once-daily oral treatment for obesity that mimics metabolic effects of gastric bypass without surgery
Rural preschoolers more likely to be living with overweight and abdominal obesity, and spend more time on screens, than their urban counterparts
Half of popular TikToks about “food noise” mention medications, mainly weight-loss drugs, to manage intrusive thoughts about food
Global survey reveals high disconnect between perceptions of obesity among people living with the disease and their doctors
Study reveals distinct mechanisms of action of tirzepatide and semaglutide
Mount Sinai Health System to honor Dennis S. Charney, MD, Dean of the Icahn School of Medicine at Mount Sinai, for 18 years of leadership and service at annual Crystal Party
Mapping a new brain network for naming
Healthcare company Watkins-Conti announces publication of positive clinical trial results for FDA-cleared Yōni.Fit bladder support
Prominent chatbots routinely exaggerate science findings, study shows
First-ever long read datasets added to two Kids First studies
Dual-laser technique lowers Brillouin sensing frequency to 200 MHz
[Press-News.org] Pharmacy benefit manager market concentration for prescriptions filled at US retail pharmaciesJAMA